Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain

OBJECTIVE: To assess the cost-effectiveness of tofacitinib-containing treatment sequences versus sequences containing only standard biological therapies in patients with moderate-to-severe rheumatoid arthritis (RA) after the failure of conventional synthetic disease-modifying antirheumatic drugs (cs...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Rheumatol
Autors principals: Navarro, F., Martinez-Sesmero, J. M., Balsa, A., Peral, C., Montoro, M., Valderrama, M., Gómez, S., de Andrés-Nogales, F., Casado, M. A., Oyagüez, Itziar
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497326/
https://ncbi.nlm.nih.gov/pubmed/32303858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-020-05087-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars